EntrezGene:3949

Symbol:	LDLR
Description:	low density lipoprotein receptor
Synonyms:	FH, FHC, LDLCQ2
Species:	Human (Homo sapiens)
Xrefs:	ExpandEntrezGene:3949 HGNC:6547 MIM:606945 Ensembl:ENSG00000130164 HPRD:06091 Vega:OTTHUMG00000171935
Associated motifs:	NA
Transcripton Factor?:	No

TSS regions

---

Copy Excel CSV PDF

Show 102550All entries

Search:

Hg19::chr19:11200089..11200098,+	p10@LDLR
Hg19::chr19:11200101..11200110,+	p8@LDLR
Hg19::chr19:11200122..11200155,+	p1@LDLR
Hg19::chr19:11200163..11200180,+	p2@LDLR
Hg19::chr19:11200181..11200193,+	p4@LDLR
Hg19::chr19:11200194..11200207,+	p5@LDLR
Hg19::chr19:11201228..11201261,+	p3@LDLR
Hg19::chr19:11201287..11201316,+	p9@LDLR
Hg19::chr19:11217362..11217367,+	p6@LDLR
Hg19::chr19:11223682..11223689,+	p7@LDLR
TSS peak ID	Short_description

Showing 1 to 10 of 10 entries

Previous1Next

View on UCSC genome browser

---

Mouse over to see Genome browser image, Click image to go to Genome browser

TSS expression

---

Copy Excel CSV PDF

Search:

Sample	p1@LDLR	p2@LDLR	p3@LDLR	p4@LDLR	p5@LDLR

Sample	p1@LDLR	p2@LDLR	p3@LDLR	p4@LDLR	p5@LDLR
immature langerhans cells, donor2.CNhs13480.11905-125F6	324.22	54.17	17.02	6.96	3.87
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6	217.07	26.16	5.23	7.02	5.74
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9	193.82	23.37	6.41	4.35	1.83
mature adipocyte, donor1.CNhs12558.12231-129F8	171.91	57.12	12.51	14.14	23.39
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6	170.26	31.40	2.09	6.98	4.19
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8	167.47	38.25	2.41	9.64	6.33
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1	166.91	26.14	5.36	8.71	6.03
Pericytes, donor1.CNhs11317.11491-119E6	156.25	27.02	1.76	6.07	5.48
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7	153.79	21.46	0.00	10.73	3.58
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2	151.93	21.89	0.53	3.69	2.90
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3	145.92	17.69	0.44	4.15	2.84
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4	143.43	43.21	1.84	5.52	4.60
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2	142.29	25.87	0.72	7.90	3.59
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9	138.18	13.05	0.26	3.33	2.56
Urothelial Cells, donor3.CNhs12122.11681-122H7	135.69	17.29	0.00	3.99	3.99
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1	132.54	12.15	0.58	5.21	2.89
Urothelial Cells, donor1.CNhs11334.11520-119H8	131.30	17.65	0.43	4.74	3.01
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2	130.84	16.17	2.94	1.47	2.94
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5	128.63	21.96	0.78	4.71	3.14
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3	125.94	16.46	0.82	4.12	3.29
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5	123.86	18.53	0.98	5.36	7.31
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1	121.96	38.11	3.27	6.53	2.18
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5	118.57	17.92	0.38	3.62	4.96
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9	117.70	23.77	1.92	4.22	3.07
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5	116.87	50.68	41.71	8.62	10.00
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2	115.58	11.76	0.57	3.73	1.43
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5	113.66	17.85	0.73	4.01	1.82
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6	113.06	16.04	0.58	5.60	2.71
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5	112.38	15.55	1.51	6.02	1.51
Urothelial Cells, donor2.CNhs12091.11600-120H7	109.51	25.27	1.68	3.37	5.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9	109.28	25.53	4.02	5.74	5.74
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2	108.87	24.10	0.00	6.65	4.99
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3	108.31	16.38	0.00	4.55	2.73
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8	103.44	13.87	0.90	3.72	3.22
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7	102.94	12.87	0.71	3.43	2.57
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3	102.71	17.41	1.07	3.55	3.20
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6	102.17	16.73	0.36	4.86	4.50
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4	101.17	13.52	1.31	3.92	3.92
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3	101.08	14.16	0.88	3.40	3.40
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2	100.52	19.92	1.12	4.48	4.25
Hepatocyte, donor3.CNhs12626.11684-122I1	99.84	28.95	1.77	8.86	8.27
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4	98.36	16.24	0.45	3.61	1.35
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3	96.88	22.19	2.96	4.81	1.85
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1	96.48	11.59	0.29	3.54	1.96
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8	96.32	10.70	2.47	4.12	4.12
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1	96.25	17.79	0.47	4.36	4.12
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8	95.54	15.74	2.25	4.50	2.25
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7	94.45	17.71	1.51	3.33	4.54
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7	94.22	22.53	1.21	4.08	5.44
mature adipocyte, donor3.CNhs12560.12233-129G1	93.74	35.23	13.48	8.88	17.46
Mallassez-derived cells, donor2.CNhs13550.11929-125I3	92.89	15.29	0.00	2.86	2.86
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2	92.73	7.52	0.00	0.00	0.00
Mallassez-derived cells, donor3.CNhs13551.11930-125I4	90.59	20.27	0.57	3.26	1.98
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6	89.71	23.11	1.60	2.75	4.81
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5	89.49	18.76	0.19	4.52	2.41
prostate cancer cell line:DU145.CNhs11260.10490-107B4	89.12	30.61	1.18	7.56	4.96
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1	89.07	34.89	28.77	7.35	12.86
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9	88.55	7.87	3.28	3.94	2.62
liver, fetal, pool1.CNhs11798.10086-102B5	87.45	10.60	5.30	5.30	5.30
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6	87.30	17.30	0.55	2.47	2.75
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5	86.59	14.39	0.27	4.00	1.33
Pericytes, donor2.CNhs12079.11571-120E5	86.47	15.10	2.40	3.09	1.72
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1	85.60	13.77	2.23	3.35	4.47
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6	84.28	16.91	0.82	3.00	3.00
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3	83.09	16.31	0.00	2.80	1.78
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8	82.74	32.26	1.40	2.80	2.80
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4	82.31	14.09	1.11	2.22	1.11
mature adipocyte, donor4.CNhs12562.12234-129G2	80.98	34.75	8.85	8.52	13.11
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7	80.24	10.37	1.65	2.25	1.80
Cardiac Myocyte, donor1.CNhs12341.11525-119I4	78.02	9.75	0.00	4.88	7.31
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4	76.91	19.46	3.37	5.05	4.30
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3	76.72	35.16	13.43	6.39	11.51
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5	76.60	18.44	0.00	2.84	0.00
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1	73.84	17.15	1.05	4.55	2.80
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6	72.61	10.57	0.27	1.63	1.08
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9	72.19	12.99	0.72	2.17	1.44
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1	72.13	11.39	0.95	3.16	1.90
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4	71.61	27.77	1.46	1.46	1.46
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3	71.06	9.32	3.49	0.00	2.33
ovary, adult, pool1.CNhs10626.10020-101D2	70.25	8.57	1.65	2.26	2.11
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6	70.22	7.97	0.00	3.86	1.29
chorionic membrane cells, donor1.CNhs12504.12238-129G6	70.18	13.40	4.15	2.55	2.23
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6	70.17	15.29	0.45	5.85	2.25
Keratocytes, donor2.CNhs12095.11607-120I5	69.68	6.24	2.08	2.08	0.00
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1	69.66	19.50	1.86	1.86	4.64
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5	69.59	10.97	1.25	3.45	2.82
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1	69.54	6.32	7.11	0.79	0.79
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8	69.18	10.64	1.06	4.61	2.48
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8	69.17	14.84	0.40	2.01	2.01
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2	69.12	8.89	0.43	2.72	2.29
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3	68.47	8.40	0.00	1.24	1.24
Sebocyte, donor1.CNhs10847.11220-116B5	67.19	8.04	0.00	4.59	2.87
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2	67.02	14.88	0.82	3.60	2.94
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3	65.93	9.40	0.46	2.00	1.31
Sebocyte, donor2.CNhs11951.11301-117B5	65.66	9.10	0.65	1.30	5.20
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3	65.59	28.44	9.58	8.71	12.77
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6	64.98	16.54	1.50	2.90	2.15
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2	64.89	15.18	0.38	2.28	3.42
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9	64.68	8.44	0.94	5.62	2.81
Melanocyte - light, donor2.CNhs11383.11351-117H1	64.47	17.58	1.17	4.69	1.17
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7	64.21	31.64	0.62	6.20	6.51
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4	64.19	6.16	2.29	0.53	0.53
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2	63.99	18.45	1.67	3.14	3.83
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6	63.96	14.98	0.58	2.30	2.88
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5	63.80	5.14	1.21	0.60	1.21
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2	63.69	17.06	0.00	3.41	3.41
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4	63.53	7.73	3.43	2.58	1.72
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4	63.49	7.96	0.61	1.84	0.61
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5	62.89	13.33	2.26	3.02	1.76
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4	62.12	15.72	0.57	3.03	2.27
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7	60.18	13.78	0.73	4.50	3.19
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5	59.98	11.63	1.22	2.45	2.45
mature adipocyte, donor2.CNhs12559.12232-129F9	59.91	44.37	12.28	10.53	16.55
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2	59.45	12.52	1.56	3.13	6.26
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9	59.28	10.74	0.20	2.59	1.39
lung, adult, pool1.CNhs10625.10019-101D1	59.27	9.29	3.95	2.46	1.07
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4	58.84	15.10	1.56	1.91	2.60
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6	58.45	13.05	1.14	2.84	1.14
Urothelial cells, donor0.CNhs10843.11216-116B1	58.35	8.27	0.69	3.45	0.23
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3	57.94	12.42	0.00	3.10	5.17
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1	57.78	9.32	1.49	2.73	1.62
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9	57.75	11.12	0.93	1.54	2.47
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9	57.35	7.20	0.28	0.83	0.83
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7	56.88	35.21	40.63	9.48	5.42
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9	56.71	10.69	0.45	2.97	1.89
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4	56.63	5.77	0.86	1.11	0.86
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8	56.06	9.84	0.86	1.71	2.14
esophagus, adult, pool1.CNhs10620.10015-101C6	55.87	7.27	2.62	1.84	0.97
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5	55.34	8.56	0.00	0.57	1.14
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7	55.29	8.85	0.49	1.47	0.98
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2	55.09	20.58	5.45	5.45	9.08
Keratinocyte - oral, donor1.CNhs10879.11251-116E9	55.00	8.80	0.74	2.31	1.57
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7	54.90	13.41	2.55	0.64	3.19
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9	54.88	11.54	1.28	3.08	1.28
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5	54.84	8.22	2.89	1.75	1.40
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8	54.56	14.46	0.78	2.80	2.18
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8	54.52	4.79	0.27	0.53	1.60
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7	54.03	8.27	0.32	2.15	1.50
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7	53.55	15.02	3.16	3.16	3.16
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3	53.36	9.00	4.50	2.65	2.65
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6	53.21	14.85	2.29	2.94	3.10
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7	52.94	9.92	3.23	2.56	0.89
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4	52.53	23.73	6.65	4.43	6.96
Hepatocyte, donor2.CNhs12349.11603-120I1	52.09	19.66	1.97	4.91	3.93
mesothelioma cell line:No36.CNhs13074.10857-111G2	51.81	14.85	0.00	1.73	4.15
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9	51.72	7.52	2.61	2.15	1.53
Cardiac Myocyte, donor3.CNhs12571.11686-122I3	51.40	7.67	0.51	2.05	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6	51.04	9.28	1.39	1.86	0.46
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8	50.93	12.01	1.92	2.26	2.18
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4	50.73	8.95	0.00	1.90	1.90
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8	50.71	9.58	0.28	3.38	1.41
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9	50.33	14.19	0.89	4.43	3.77
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3	50.03	4.55	0.00	2.27	0.00
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3	49.74	11.62	2.62	2.25	2.00
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7	49.73	6.91	2.76	1.38	0.00
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5	49.71	11.27	2.65	3.98	2.98
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9	49.58	7.21	0.69	2.06	1.54
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6	49.43	14.74	0.61	3.99	2.46
leiomyoma cell line:10964C.CNhs11722.10569-108B2	49.41	8.14	1.09	2.71	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2	49.12	8.76	0.00	2.28	2.28
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7	49.06	7.67	0.00	0.00	1.53
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6	49.01	8.29	0.74	2.72	2.48
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1	48.98	19.16	1.01	2.59	1.73
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1	48.85	9.04	0.82	2.70	1.88
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9	48.60	8.43	0.28	3.23	0.84
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5	48.58	20.55	12.46	7.47	9.97
myeloma cell line:PCM6.CNhs11258.10474-106I6	48.56	8.96	1.21	2.41	1.03
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9	48.42	9.45	1.35	3.09	1.35
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3	48.22	11.31	0.57	2.26	0.71
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5	47.80	7.38	0.88	1.50	1.13
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4	47.50	8.66	0.63	1.79	1.58
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9	47.43	9.11	2.70	1.52	1.69
Meningeal Cells, donor1.CNhs11320.11493-119E8	47.32	10.09	0.78	2.35	2.35
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3	47.28	8.53	0.42	2.10	1.54
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4	47.17	8.34	0.97	2.37	1.58
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5	47.02	7.50	1.50	2.50	2.50
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4	47.01	14.63	1.57	1.31	2.61
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2	46.98	10.32	0.46	1.85	1.54
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1	46.98	11.94	0.40	1.59	0.80
Mast cell - stimulated, donor1.CNhs11073.11487-119E2	46.80	9.85	0.99	1.97	0.49
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1	46.10	8.84	0.34	2.21	1.19
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2	46.01	7.42	2.97	4.45	1.48
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5	45.81	8.74	0.65	3.08	1.46
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5	45.78	8.10	0.66	2.31	0.50
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3	45.26	12.23	0.82	2.58	2.31
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2	45.25	14.76	13.48	2.89	4.81
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6	45.18	28.40	21.30	5.81	5.81
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9	45.05	9.88	1.45	2.03	1.74
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5	44.56	8.85	2.48	1.24	0.78
stomach, fetal, donor1.CNhs11771.10062-101H8	44.55	13.15	7.30	2.19	4.38
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7	44.38	12.86	0.64	2.57	3.86
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8	44.35	6.78	2.09	2.09	1.04
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1	44.32	9.34	0.60	2.39	1.99
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2	43.76	7.10	0.84	1.69	1.35
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3	43.58	6.88	4.01	1.72	6.31
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3	43.46	16.20	8.84	2.95	8.10
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2	43.18	10.72	0.92	3.06	3.06
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5	43.09	5.89	0.00	1.68	0.34
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7	42.97	9.15	3.56	0.76	1.27
Melanocyte - light, donor3.CNhs12033.11423-118G1	42.77	8.55	0.00	3.42	3.42
Meningeal Cells, donor2.CNhs12080.11573-120E7	42.72	10.03	1.31	3.05	2.18
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6	42.68	13.68	1.00	2.26	1.26
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6	42.55	8.78	2.93	0.73	0.24
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1	42.53	9.40	1.27	1.91	1.12
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1	42.47	12.47	1.48	1.90	2.75
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1	42.45	11.30	0.96	1.79	1.93
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2	42.06	8.58	0.12	1.93	0.60
glioblastoma cell line:A172.CNhs11185.10444-106F3	42.05	12.24	0.84	3.14	3.66
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4	41.93	9.37	0.00	1.73	1.97
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7	41.90	9.03	0.67	2.29	1.62
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6	41.86	10.71	0.49	1.48	1.72
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5	41.62	5.77	0.75	0.25	0.75
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6	41.41	13.50	8.40	3.90	1.50
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3	41.20	16.52	2.86	4.28	3.57
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4	41.13	2.09	2.09	0.70	1.39
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7	41.00	6.89	0.33	1.97	0.98
Cardiac Myocyte, donor2.CNhs12350.11605-120I3	40.91	7.38	2.01	0.67	2.01
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1	40.89	12.69	1.41	0.00	2.82
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3	40.82	18.84	0.78	2.35	0.78
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6	40.68	3.39	1.13	1.13	0.00
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2	40.55	11.92	0.77	1.92	2.50
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8	40.41	10.10	0.00	4.33	2.89
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4	40.24	10.21	1.08	1.37	0.69
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1	40.02	7.83	0.00	0.87	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1	39.85	8.37	0.14	2.45	1.73
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1	39.80	10.09	5.33	1.68	1.40
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1	39.73	8.65	0.66	1.05	1.97
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3	39.67	7.56	0.63	0.94	2.83
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3	39.61	4.79	0.27	1.06	1.60
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8	39.47	7.44	0.21	0.93	0.93
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4	39.46	8.73	1.64	1.64	1.64
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5	39.31	7.47	0.75	1.64	1.20
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7	39.27	5.56	0.35	1.13	0.78
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3	39.05	13.14	6.75	2.84	3.91
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9	39.04	12.01	1.13	3.12	2.93
cervical cancer cell line:ME-180.CNhs11289.10553-107I4	39.04	10.32	1.81	2.09	1.53
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8	39.02	8.51	0.23	1.36	0.91
leiomyoma cell line:15242A.CNhs11723.10570-108B3	38.89	7.78	0.86	1.73	1.73
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5	38.81	10.15	0.33	1.64	1.97
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9	38.71	5.31	1.25	1.25	1.56
Preadipocyte - omental, donor3.CNhs12013.11403-118D8	38.60	4.50	0.48	0.80	0.48
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6	38.55	14.38	12.08	5.18	2.88
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1	38.16	6.38	0.86	2.33	0.98
heart - tricuspid valve, adult.CNhs12857.10207-103F9	38.05	12.92	1.44	4.31	1.44
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8	37.99	7.60	0.00	0.00	10.13
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7	37.93	7.38	1.01	1.85	0.84
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9	37.65	13.29	0.00	2.21	2.95
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9	37.31	9.33	2.51	2.33	2.69
mesothelioma cell line:ONE58.CNhs13075.10858-111G3	37.07	8.51	0.00	2.13	1.52
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1	37.01	13.88	3.08	3.08	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6	36.94	3.46	1.15	1.54	1.15
salivary acinar cells, donor1.CNhs12810.11771-123I7	36.88	9.95	0.00	1.66	0.83
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3	36.87	4.14	1.24	0.41	0.41
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4	36.87	9.26	1.89	1.89	1.54
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6	36.86	9.59	4.04	2.02	2.78
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8	36.75	5.09	0.00	2.26	1.13
prostate cancer cell line:PC-3.CNhs11243.10439-106E7	36.71	7.67	1.56	0.89	0.56
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5	36.69	9.35	0.55	2.02	2.38
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1	36.20	7.58	0.69	1.03	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5	36.19	5.03	0.29	0.77	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9	35.66	6.22	0.83	0.83	1.66
gall bladder, adult.CNhs12848.10198-103E9	35.65	11.31	4.06	2.35	3.20
thalamus - adult, donor10196.CNhs13794.10168-103B6	35.65	13.27	2.49	2.49	0.83
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2	35.52	8.65	1.87	1.87	1.17
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1	35.45	10.65	0.77	2.47	1.28
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1	35.38	7.97	0.23	2.34	0.94
Preadipocyte - omental, donor1.CNhs11065.11468-119C1	35.37	3.84	0.00	1.41	0.38
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2	35.37	8.78	0.43	2.22	0.85
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3	35.14	6.72	0.26	1.03	0.78
Adipocyte - omental, donor2.CNhs12067.11474-119C7	35.03	11.01	0.00	0.00	1.00
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7	34.99	5.99	0.47	0.47	0.94
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4	34.87	7.93	0.00	4.76	0.00
Keratocytes, donor1.CNhs11337.11527-119I6	34.86	8.15	0.00	1.30	0.65
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5	34.74	4.74	1.80	1.80	1.13
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9	34.61	14.54	1.47	3.31	1.66
Adipocyte - breast, donor2.CNhs11969.11327-117E4	34.47	7.92	0.64	2.57	1.07
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4	34.44	6.52	0.12	1.35	0.74
Adipocyte - omental, donor3.CNhs12068.11475-119C8	34.42	4.92	0.45	2.23	1.34
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1	34.23	14.43	0.24	2.16	2.32
Hepatocyte, donor1.CNhs12340.11523-119I2	34.22	10.14	5.07	1.27	3.80
uterus, fetal, donor1.CNhs11763.10055-101H1	34.18	5.70	1.63	1.22	0.41
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4	34.16	4.27	1.07	1.07	2.13
breast, adult, donor1.CNhs11792.10080-102A8	34.07	5.07	3.62	0.72	0.72
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5	33.86	6.27	0.55	1.43	0.88
CD14+ Monocytes, donor3.CNhs11997.11381-118B4	33.85	55.12	28.21	15.84	23.00
Mesothelial Cells, donor1.CNhs10850.11247-116E5	33.76	4.22	0.30	0.00	1.21
Basophils, donor3.CNhs12575.12243-129H2	33.75	23.53	23.07	6.50	3.72
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9	33.64	5.83	3.36	1.46	1.46
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5	33.58	6.78	1.23	0.62	0.62
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8	33.53	7.00	1.46	2.62	0.87
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8	33.26	3.17	0.79	1.58	0.79
Melanocyte - light, donor1.CNhs11303.11274-116H5	33.23	3.06	0.38	1.91	1.53
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9	33.15	6.98	0.87	0.00	0.00
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6	32.90	6.55	0.41	0.82	1.23
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2	32.85	8.90	1.51	2.33	1.51
Mast cell, donor1.CNhs12566.11563-120D6	32.84	2.91	0.79	0.97	0.44
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3	32.73	7.77	2.77	2.22	1.11
CD14+ Monocytes, donor1.CNhs10852.11224-116B9	32.69	39.33	9.97	9.42	16.62
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3	32.53	7.69	0.15	1.92	1.48
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3	32.46	9.53	5.67	2.83	2.06
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6	32.41	10.19	2.31	3.70	2.78
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9	32.32	6.72	0.52	0.90	0.90
Preadipocyte - breast, donor2.CNhs11971.11328-117E5	32.28	5.33	0.00	0.84	0.28
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3	32.24	5.68	0.37	1.28	1.65
heart - mitral valve, adult.CNhs12855.10205-103F7	32.12	7.26	1.68	2.51	1.12
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2	32.01	5.43	0.29	1.14	0.29
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8	31.95	5.58	0.86	2.14	1.93
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1	31.95	9.35	0.71	2.96	1.77
Mesothelial Cells, donor3.CNhs12012.11402-118D7	31.89	5.70	0.20	1.20	0.90
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3	31.83	9.46	0.86	0.86	1.72
CD34+ Progenitors, donor1.CNhs13227.11545-120B6	31.72	17.18	10.57	5.29	3.97
Mast cell, donor2.CNhs12594.11565-120D8	31.72	16.79	31.93	3.52	2.07
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5	31.62	3.33	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6	31.61	10.46	7.90	3.49	2.32
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1	31.41	5.32	0.00	1.60	0.53
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8	31.40	8.97	0.00	1.12	0.56
Preadipocyte - omental, donor2.CNhs11902.11329-117E6	31.21	5.63	0.00	1.54	0.00
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8	31.13	4.79	1.20	0.00	1.20
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2	31.08	7.04	1.21	1.46	1.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5	30.92	10.99	1.03	2.75	1.03
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1	30.92	5.12	0.53	1.06	1.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6	30.78	6.67	0.98	1.57	1.76
Melanocyte - dark, donor3.CNhs12570.11663-122F7	30.73	5.33	0.06	1.27	1.27
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9	30.72	9.59	1.23	1.72	1.97
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1	30.66	10.58	0.65	1.08	0.86
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8	30.66	5.96	1.28	0.43	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5	30.64	12.68	0.00	1.06	2.11
glioma cell line:GI-1.CNhs10731.10413-106B8	30.63	7.22	1.73	1.44	0.29
spinal cord - adult, donor10196.CNhs13807.10181-103D1	30.43	7.26	5.30	0.59	1.96
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3	30.38	10.44	2.85	0.95	2.85
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2	30.33	7.17	1.10	0.00	1.10
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3	30.28	9.41	1.18	1.67	1.67
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9	30.04	4.07	0.68	1.19	1.02
Basophils, donor1.CNhs12546.12241-129G9	29.90	28.32	24.39	6.69	5.11
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4	29.90	2.88	0.00	0.36	0.72
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3	29.88	4.27	0.36	1.07	1.42
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8	29.85	4.83	0.88	1.32	0.88
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7	29.85	6.63	0.00	2.65	1.33
spinal cord, fetal, donor1.CNhs11764.10056-101H2	29.59	5.49	0.85	1.69	0.00
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2	29.48	11.64	2.84	2.20	3.36
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3	29.45	5.56	0.30	1.20	0.75
corpus callosum, adult, pool1.CNhs10649.10042-101F6	29.32	2.97	2.63	1.08	1.01
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8	29.30	4.92	0.00	1.23	0.00
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6	28.89	8.56	0.00	1.78	1.07
chorionic membrane cells, donor3.CNhs12380.12240-129G8	28.78	10.66	0.53	2.67	2.13
Osteoblast, donor3.CNhs12036.11426-118G4	28.76	5.90	1.11	1.66	0.18
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6	28.73	5.67	0.00	1.06	0.71
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7	28.51	5.94	0.00	0.00	0.00
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3	28.47	8.61	0.69	1.61	1.84
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7	28.41	4.11	0.49	1.48	0.41
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8	28.14	12.81	16.33	4.02	2.01
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7	28.08	4.16	0.00	0.00	1.04
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4	28.04	3.51	0.40	0.94	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5	27.97	6.27	0.41	1.82	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9	27.95	7.07	0.00	1.01	0.34
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8	27.90	4.65	0.20	1.62	0.81
Mesothelial Cells, donor2.CNhs12197.12156-128G5	27.89	4.36	0.00	0.87	0.00
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7	27.87	5.41	1.66	0.62	1.25
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1	27.84	5.80	0.94	1.69	0.74
trachea, adult, pool1.CNhs10635.10029-101E2	27.83	6.17	1.65	1.65	1.43
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8	27.67	8.28	11.82	1.89	1.42
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3	27.65	6.99	0.00	1.34	1.04
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4	27.65	5.09	0.79	0.64	1.11
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8	27.57	6.51	1.24	1.24	0.31
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9	27.50	6.06	0.74	1.48	1.48
Adipocyte - omental, donor1.CNhs11054.11473-119C6	27.49	4.23	0.14	1.41	1.27
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5	27.36	7.32	0.34	2.36	1.80
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4	27.36	7.86	1.73	2.36	2.20
throat, adult.CNhs12858.10209-103G2	27.29	5.54	1.28	0.64	0.43
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2	27.19	5.44	1.43	3.43	0.86
hepatoma cell line:Li-7.CNhs11271.10484-107A7	27.07	9.35	0.89	1.08	1.08
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9	27.03	6.26	0.82	1.24	0.66
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6	26.95	22.79	4.17	3.68	4.66
Myoblast, donor2.CNhs11965.11322-117D8	26.92	5.14	0.62	1.64	1.64
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1	26.88	4.90	1.30	0.70	0.60
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8	26.87	3.98	0.43	0.57	0.43
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4	26.80	4.54	0.09	1.25	0.53
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3	26.80	8.46	1.41	2.12	2.12
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2	26.69	10.38	1.48	3.26	0.89
trachea, fetal, donor1.CNhs11766.10058-101H4	26.61	1.33	2.00	0.33	0.00
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5	26.59	4.43	1.21	0.40	1.61
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2	26.46	2.41	0.00	2.41	0.80
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6	26.34	4.70	3.29	0.47	1.88
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5	26.29	7.92	0.63	1.69	0.95
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4	26.22	4.94	0.21	1.23	0.31
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4	26.10	13.62	7.38	2.84	5.11
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6	26.04	8.00	0.32	2.03	2.77
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7	25.87	7.02	0.00	0.44	0.88
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8	25.69	5.21	0.69	1.39	1.74
CD14+ Monocytes, donor2.CNhs11954.11305-117B9	25.67	37.50	12.23	9.43	13.24
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3	25.55	8.43	2.94	2.94	2.04
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5	25.54	6.08	1.22	1.22	0.00
leiomyoma cell line:15425.CNhs11724.10571-108B4	25.47	4.57	0.65	0.00	0.98
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8	25.41	6.18	1.37	0.34	0.69
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9	25.27	8.04	0.00	1.15	4.59
skin, fetal, donor1.CNhs11774.10065-101I2	25.26	7.29	0.49	1.94	1.94
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3	25.23	5.41	0.30	0.60	0.30
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2	25.18	5.39	0.80	1.60	1.20
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2	25.10	8.79	0.72	1.79	1.79
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8	24.98	4.82	1.25	1.07	0.71
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3	24.96	8.32	1.42	1.42	0.81
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4	24.86	7.21	0.00	1.33	1.14
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7	24.85	14.09	7.43	2.56	1.28
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5	24.83	5.15	1.55	2.16	2.06
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7	24.82	5.09	1.59	2.23	1.27
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4	24.70	11.65	4.59	1.41	2.82
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3	24.69	4.94	0.38	1.14	1.27
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4	24.67	5.08	2.64	0.66	0.66
Meningeal Cells, donor3.CNhs12731.11654-122E7	24.64	4.84	0.07	1.91	2.35
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1	24.60	5.65	0.33	1.99	0.50
tongue, adult.CNhs12853.10203-103F5	24.60	9.36	1.09	0.65	0.65
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3	24.58	8.32	7.80	1.17	1.43
Preadipocyte - breast, donor1.CNhs11052.11467-119B9	24.56	3.97	0.00	0.00	0.74
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8	24.48	2.01	0.15	0.23	0.15
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1	24.47	4.65	1.70	1.36	0.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8	24.34	5.83	0.95	1.02	0.55
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2	24.28	6.37	0.71	1.32	1.21
b cell line:RPMI1788.CNhs10744.10427-106D4	24.25	4.92	2.09	1.23	0.37
parietal lobe - adult, donor10196.CNhs13797.10171-103B9	24.21	2.34	0.78	0.00	0.00
Basophils, donor2.CNhs12563.12242-129H1	24.18	21.88	13.05	1.92	5.76
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5	24.14	4.12	0.78	0.59	0.59
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4	24.02	7.12	4.45	1.78	1.78
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1	23.88	6.57	1.79	1.49	0.90
medulla oblongata, adult, pool1.CNhs10645.10038-101F2	23.85	5.40	1.49	1.30	0.81
small intestine, adult, pool1.CNhs10630.10024-101D6	23.85	5.48	0.23	1.39	0.69
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6	23.72	4.26	0.56	0.56	0.93
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2	23.47	4.50	1.17	0.59	0.59
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2	23.30	3.11	1.77	1.33	0.44
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8	23.22	3.84	2.69	0.58	0.96
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8	23.19	8.43	0.00	2.11	0.00
uterus, adult, pool1.CNhs11676.10100-102D1	23.10	4.03	1.83	0.98	0.86
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7	22.99	33.21	0.00	10.22	2.55
amniotic membrane cells, donor1.CNhs12502.12235-129G3	22.92	3.82	0.72	0.24	0.72
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4	22.74	3.16	0.63	1.90	0.63
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7	22.72	5.33	0.58	2.55	0.70
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8	22.37	5.49	0.63	1.05	1.05
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8	22.32	5.50	0.43	0.97	0.43
liver, adult, pool1.CNhs10624.10018-101C9	22.28	8.50	0.59	3.37	3.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1	22.22	2.40	0.00	0.65	0.22
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8	22.15	6.13	0.34	1.02	1.36
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8	22.07	3.98	0.31	0.92	1.23
tonsil, adult, pool1.CNhs10654.10047-101G2	22.02	2.49	0.61	0.67	0.40
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2	21.97	5.29	0.81	0.81	0.00
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7	21.96	4.82	0.00	1.16	0.00
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2	21.82	6.51	1.30	1.30	0.98
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1	21.50	14.12	13.03	1.95	1.30
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4	21.48	5.48	0.42	0.84	1.26
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1	21.48	10.38	1.07	1.79	1.61
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9	21.47	6.48	0.72	1.44	0.86
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1	21.45	3.37	0.00	0.24	0.00
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9	21.32	6.27	0.84	0.84	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5	21.22	6.11	2.57	2.09	1.13
lung, fetal, donor1.CNhs11680.10068-101I5	21.22	4.40	1.57	2.20	1.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9	21.17	6.93	1.09	0.73	1.82
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8	21.14	6.43	4.04	1.19	0.83
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6	21.13	5.92	0.00	0.85	1.69
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3	21.07	3.70	1.79	0.11	0.00
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8	21.06	6.50	10.53	0.93	2.17
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5	21.05	2.80	1.81	0.99	0.33
appendix, adult.CNhs12842.10189-103D9	21.00	4.42	2.76	1.66	0.28
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5	20.97	4.59	0.33	1.31	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2	20.88	4.27	0.24	1.42	0.71
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3	20.76	3.31	1.59	0.79	0.93
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9	20.74	5.29	1.06	0.42	1.48
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3	20.64	8.53	0.00	1.85	1.11
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4	20.60	4.75	0.18	0.90	0.81
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8	20.57	3.63	4.84	0.00	1.21
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6	20.54	2.63	0.37	0.88	1.17
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4	20.53	4.79	0.17	0.86	0.51
Natural Killer Cells, donor2.CNhs11957.11311-117C6	20.48	19.84	13.15	2.16	2.16
meningioma cell line:HKBMM.CNhs11945.10691-109F7	20.47	3.06	0.94	1.41	1.18
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9	20.36	4.40	0.28	1.10	1.10
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9	20.28	3.52	0.00	1.35	0.27
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3	20.27	9.56	1.15	1.81	1.81
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3	20.21	4.81	0.00	0.00	1.92
liposarcoma cell line:SW 872.CNhs11851.10726-110A6	20.17	7.82	2.49	2.15	1.70
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3	20.17	4.03	0.81	1.01	1.01
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7	20.08	4.35	0.33	2.34	0.67
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6	19.95	5.21	2.60	1.61	0.99
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8	19.88	5.38	1.40	2.57	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9	19.82	10.43	7.82	2.61	1.04
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6	19.71	5.26	0.57	0.64	0.57
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8	19.66	4.91	0.23	0.70	0.00
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8	19.57	2.12	1.06	1.06	0.53
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5	19.55	6.09	1.28	0.64	0.00
tenocyte, donor2.CNhs12640.11765-123I1	19.41	6.47	0.92	1.39	2.31
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1	19.38	5.98	0.00	1.43	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9	19.34	2.76	1.11	0.55	0.28
Natural Killer Cells, donor1.CNhs10859.11230-116C6	19.31	13.00	8.87	3.15	2.76
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5	19.31	7.28	1.53	1.08	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2	19.22	8.75	0.19	2.09	1.33
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6	19.18	5.30	0.88	1.77	0.76
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7	19.13	10.56	4.29	0.66	1.65
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9	19.05	3.03	0.00	0.67	1.01
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7	19.04	5.44	0.00	0.74	0.99
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8	18.99	4.47	0.00	0.00	2.79
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4	18.95	8.32	1.96	1.96	1.39
bladder, adult, pool1.CNhs10616.10011-101C2	18.94	5.13	1.48	0.69	0.99
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2	18.89	4.45	2.22	2.22	2.22
spleen, fetal, pool1.CNhs10651.10044-101F8	18.89	6.06	0.64	1.42	0.84
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7	18.69	2.60	0.52	0.52	0.52
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8	18.69	5.95	0.31	1.78	0.42
pons, adult, pool1.CNhs10640.10033-101E6	18.69	3.94	0.88	1.02	0.82
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8	18.57	5.25	5.89	0.51	1.02
diaphragm, fetal, donor1.CNhs11779.10069-101I6	18.46	5.62	0.80	0.80	0.80
brain, adult, donor1.CNhs11796.10084-102B3	18.42	2.91	0.97	0.00	0.00
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1	18.41	4.49	0.45	0.90	1.35
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9	18.33	8.52	6.39	0.43	1.28
Neural stem cells, donor2.CNhs11384.11352-117H2	18.22	6.51	0.00	0.00	0.00
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8	18.09	3.76	0.54	0.54	0.54
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1	18.05	5.54	1.77	1.18	1.18
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4	17.98	3.98	0.80	1.59	0.91
vagina, adult.CNhs12854.10204-103F6	17.98	6.66	3.33	1.33	0.67
CD34+ Progenitors, donor2.CNhs12205.11625-122B5	17.94	24.66	3.36	5.61	4.48
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4	17.83	5.46	2.09	0.64	0.48
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1	17.73	4.55	0.48	0.24	0.24
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2	17.55	3.18	2.67	0.33	0.33
Myoblast, donor3.CNhs11908.11398-118D3	17.55	3.94	0.00	0.54	0.36
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5	17.55	4.14	0.00	1.22	0.00
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9	17.53	5.23	0.85	0.42	0.57
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7	17.51	6.37	2.19	0.99	0.80
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9	17.48	3.64	0.36	0.91	0.73
tenocyte, donor1.CNhs12639.11763-123H8	17.48	3.72	1.12	0.74	1.49
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6	17.40	4.97	0.53	1.07	0.89
astrocytoma cell line:TM-31.CNhs10742.10425-106D2	17.39	5.62	0.00	0.51	0.51
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1	17.38	11.58	0.00	1.93	0.00
aorta, adult, pool1.CNhs11760.10052-101G7	17.33	5.98	4.78	1.20	1.39
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6	17.23	4.56	0.89	1.01	1.27
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8	17.15	2.01	0.00	0.59	0.00
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5	17.09	4.56	0.34	1.82	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6	17.03	4.49	0.27	1.47	0.37
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2	17.03	4.82	1.03	0.69	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9	16.99	3.64	0.66	0.88	0.66
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6	16.99	3.66	0.00	0.33	1.00
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4	16.94	10.35	5.46	1.69	1.32
Natural Killer Cells, donor3.CNhs12001.11387-118C1	16.94	16.56	13.48	2.82	1.67
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8	16.75	6.78	6.18	0.80	0.80
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2	16.75	7.16	0.86	0.57	0.86
Myoblast, donor1.CNhs10870.11241-116D8	16.51	3.62	0.58	0.29	0.29
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1	16.50	3.14	1.24	0.52	0.46
chorionic membrane cells, donor2.CNhs12506.12239-129G7	16.49	1.74	0.73	0.37	0.27
colon, adult, pool1.CNhs10619.10014-101C5	16.45	3.63	0.88	0.80	0.62
Neurons, donor1.CNhs12338.11494-119E9	16.24	6.19	5.41	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9	16.23	4.06	0.87	1.16	0.00
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6	16.21	3.24	0.23	1.16	0.93
smooth muscle, adult, pool1.CNhs11755.10048-101G3	16.18	4.66	1.72	1.23	1.23
kidney, fetal, pool1.CNhs10652.10045-101F9	16.16	2.31	0.89	0.42	0.37
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5	16.14	4.03	0.67	2.02	0.00
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9	16.14	6.54	4.51	0.87	0.44
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2	16.05	2.83	0.61	0.76	0.38
gastric cancer cell line:AZ521.CNhs11286.10549-107H9	16.04	5.04	0.11	1.60	1.03
colon, adult, donor1.CNhs11794.10082-102B1	15.92	1.99	1.00	1.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7	15.92	4.06	0.76	0.76	0.51
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3	15.90	6.45	0.00	1.72	0.43
hippocampus - adult, donor10196.CNhs13795.10169-103B7	15.90	5.57	1.59	2.39	0.00
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2	15.75	2.17	0.33	0.54	0.33
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9	15.52	3.88	0.68	1.14	0.46
Mast cell, donor4.CNhs12592.11567-120E1	15.40	6.06	34.97	2.27	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5	15.29	9.56	0.00	1.91	0.96
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6	15.27	3.70	0.46	1.08	0.15
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7	15.19	2.85	0.28	0.55	0.18
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9	15.17	3.03	0.61	1.21	0.73
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4	15.13	6.19	2.20	2.20	0.96
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6	15.04	6.02	0.00	1.00	0.50
melanoma cell line:COLO 679.CNhs11281.10514-107E1	15.01	3.64	0.15	0.45	0.61
thalamus, adult, donor10252.CNhs12314.10154-103A1	15.00	2.17	1.86	0.62	0.72
nasal epithelial cells, donor2.CNhs12574.12227-129F4	14.93	5.60	1.24	0.62	0.00
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2	14.80	7.52	6.31	1.46	0.73
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4	14.76	4.42	0.35	1.74	1.51
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5	14.58	7.95	0.53	0.93	1.19
Synoviocyte, donor2.CNhs11992.11368-117I9	14.57	7.18	1.90	2.32	1.90
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2	14.56	2.65	0.66	0.00	0.33
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6	14.39	4.15	0.85	0.73	0.24
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5	14.37	6.16	2.30	1.48	0.90
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6	14.34	3.31	0.37	1.47	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5	14.33	3.58	0.22	0.22	0.22
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9	14.32	4.21	0.28	0.56	0.56
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7	14.24	14.24	3.67	4.10	4.53
umbilical cord, fetal, donor1.CNhs11765.10057-101H3	14.08	2.35	0.00	4.69	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2	14.06	4.52	0.00	1.51	1.00
glioblastoma cell line:T98G.CNhs11272.10485-107A8	13.97	3.16	0.71	0.61	0.61
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7	13.96	2.79	0.00	0.40	0.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8	13.71	4.07	1.74	0.58	0.46
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4	13.67	4.24	1.18	0.71	0.47
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7	13.66	4.26	1.20	0.87	1.09
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7	13.58	2.80	0.83	0.93	0.31
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9	13.57	3.00	0.32	0.47	0.32
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9	13.39	1.80	0.00	0.52	0.00
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7	13.34	4.16	1.17	0.85	0.32
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3	13.26	4.23	4.57	0.33	0.45
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8	13.08	3.23	0.34	0.34	0.00
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9	13.03	2.43	0.61	0.30	0.00
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4	12.84	4.28	1.43	1.43	0.00
submaxillary gland, adult.CNhs12852.10202-103F4	12.84	2.29	0.46	0.00	0.00
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3	12.76	1.16	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7	12.75	6.58	4.93	1.64	0.82
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4	12.67	1.73	0.39	0.47	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4	12.66	0.60	0.60	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8	12.57	3.39	0.40	0.60	0.80
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3	12.56	3.57	0.81	0.81	0.35
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3	12.47	3.30	0.00	0.41	0.41
cervix, adult, pool1.CNhs10618.10013-101C4	12.47	2.62	0.62	0.77	0.62
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6	12.40	6.20	5.31	0.00	0.89
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2	12.33	5.76	1.78	0.82	0.69
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9	12.29	1.06	0.21	0.85	0.42
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7	12.25	1.95	0.84	0.28	0.84
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3	12.23	2.13	0.74	0.33	0.41
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1	12.20	5.37	0.00	0.49	0.24
parietal lobe, adult, pool1.CNhs10641.10034-101E7	12.18	2.03	0.76	0.57	0.38
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1	12.16	5.32	0.00	0.00	0.00
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9	12.15	2.03	0.28	0.46	0.28
Neurons, donor3.CNhs13815.11655-122E8	12.12	3.19	3.83	0.00	0.64
tenocyte, donor3.CNhs12641.11768-123I4	12.11	2.60	0.87	0.43	1.73
retina, adult, pool1.CNhs10636.10030-101E3	12.08	2.36	0.64	0.71	0.57
placenta, adult, pool1.CNhs10627.10021-101D3	12.06	3.37	1.24	0.89	0.62
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9	11.95	2.39	1.19	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9	11.94	4.34	0.54	1.63	0.00
immature langerhans cells, donor1.CNhs13537.11904-125F5	11.92	5.62	0.67	1.12	0.45
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2	11.91	2.46	0.16	0.57	0.74
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8	11.86	3.31	0.00	0.85	0.85
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4	11.78	3.39	0.54	0.36	0.36
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6	11.76	2.40	1.34	0.27	0.27
salivary acinar cells, donor3.CNhs12812.11773-123I9	11.75	1.38	2.77	0.00	1.38
CD8+ T Cells, donor1.CNhs10854.11226-116C2	11.69	10.48	10.28	1.21	1.21
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4	11.69	2.14	0.19	0.58	0.39
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1	11.64	1.94	0.32	0.65	0.48
middle temporal gyrus, donor10252.CNhs12316.10156-103A3	11.61	2.63	0.55	0.28	0.28
adipose tissue, adult, pool1.CNhs10615.10010-101C1	11.57	4.98	0.44	1.61	1.32
spleen, adult, pool1.CNhs10631.10025-101D7	11.56	3.85	0.00	1.50	1.22
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7	11.55	5.66	4.24	0.47	1.18
testis, adult, pool2.CNhs12998.10096-102C6	11.52	0.80	3.48	0.00	0.00
Reticulocytes, biol_rep2.CNhs13553.11932-125I6	11.50	3.14	0.26	1.05	0.52
occipital cortex, adult, donor10252.CNhs12320.10163-103B1	11.49	2.39	1.28	0.80	0.32
optic nerve, donor1.CNhs13449.10277-104E7	11.42	0.00	1.43	1.43	0.00
globus pallidus - adult, donor10196.CNhs13801.10175-103C4	11.41	4.20	1.20	1.20	2.40
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8	11.41	2.63	0.74	0.61	0.27
prostate, adult, pool1.CNhs10628.10022-101D4	11.38	2.28	0.78	0.86	0.55
parietal lobe, adult, donor10252.CNhs12317.10157-103A4	11.37	2.27	1.86	0.62	0.21
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6	11.36	1.36	0.17	0.34	0.51
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9	11.35	2.52	1.10	0.63	0.16
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1	11.20	1.20	0.00	0.00	0.80
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6	11.15	3.33	0.14	1.01	0.58
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6	11.11	2.30	0.77	0.57	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6	11.05	4.83	0.69	2.07	0.00
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6	11.04	3.25	0.65	0.00	1.08
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6	10.95	2.92	0.73	0.73	0.00
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1	10.95	0.91	0.55	0.18	0.00
penis, adult.CNhs12850.10200-103F2	10.92	3.47	0.00	0.50	0.00
CD4+ T Cells, donor3.CNhs11998.11382-118B5	10.90	7.81	11.92	1.44	0.62
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1	10.89	1.76	0.35	0.70	0.23
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5	10.88	2.95	0.00	0.45	0.91
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5	10.79	3.16	0.00	0.37	0.37
heart - pulmonic valve, adult.CNhs12856.10206-103F8	10.77	1.60	0.00	0.46	0.00
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6	10.77	1.41	0.00	0.47	0.00
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8	10.68	2.56	0.00	0.21	0.21
brain, adult, pool1.CNhs10617.10012-101C3	10.67	3.34	0.46	0.83	1.02
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6	10.56	6.29	4.05	0.67	0.67
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2	10.53	4.27	1.71	0.28	0.57
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4	10.50	2.28	0.57	0.57	0.24
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3	10.46	2.18	0.33	0.87	0.44
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6	10.40	5.60	0.80	1.00	0.60
colon, fetal, donor1.CNhs11780.10070-101I7	10.39	1.83	2.44	0.61	0.00
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2	10.38	2.12	0.10	0.20	0.10
salivary gland, adult, pool1.CNhs11677.10093-102C3	10.33	2.15	1.72	0.43	0.00
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2	10.30	2.67	0.00	0.38	0.38
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1	10.28	1.28	0.39	0.19	0.13
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7	10.23	2.05	3.07	1.02	0.51
CD4+ T Cells, donor2.CNhs11955.11306-117C1	10.22	11.79	12.58	1.18	1.97
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2	10.22	3.07	0.00	1.02	0.00
Synoviocyte, donor3.CNhs12050.11440-118H9	10.21	3.62	1.32	0.99	0.66
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6	10.17	3.52	0.59	0.59	0.78
CD8+ T Cells, donor2.CNhs11956.11307-117C2	10.16	8.83	10.70	1.60	0.53
temporal lobe, adult, pool1.CNhs10637.10031-101E4	10.13	1.84	0.75	0.27	0.27
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4	10.11	2.57	0.75	0.60	0.30
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3	10.09	2.52	0.00	2.52	0.00
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2	10.03	11.74	2.24	3.31	3.31
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1	9.98	5.58	1.76	1.76	0.88
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1	9.97	3.99	0.00	0.00	0.00
Osteoblast, donor2.CNhs11385.11354-117H4	9.96	1.33	0.00	0.00	0.00
epididymis, adult.CNhs12847.10197-103E8	9.96	2.45	1.57	0.00	0.52
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3	9.95	2.16	0.00	0.29	0.14
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6	9.93	1.08	1.51	0.22	0.43
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8	9.75	1.77	0.00	0.89	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5	9.73	1.12	0.00	0.32	0.00
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3	9.73	5.34	0.94	0.94	0.63
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2	9.72	3.24	1.62	0.00	1.62
Reticulocytes, biol_rep1.CNhs13552.11931-125I5	9.65	1.75	0.66	0.22	0.44
CD4+ T Cells, donor1.CNhs10853.11225-116C1	9.64	9.44	10.03	0.39	1.38
Sertoli Cells, donor1.CNhs10851.11255-116F4	9.64	3.21	0.00	0.00	0.00
heart, adult, pool1.CNhs10621.10016-101C7	9.60	6.92	0.22	1.12	1.12
amygdala, adult, donor10252.CNhs12311.10151-102I7	9.57	1.55	1.69	0.42	0.00
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7	9.54	2.39	0.00	0.00	0.80
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5	9.39	0.97	0.65	0.32	0.00
pancreas, adult, donor1.CNhs11756.10049-101G4	9.38	2.34	0.00	0.78	1.56
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6	9.34	3.03	1.26	0.50	0.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5	9.27	3.42	0.49	0.00	0.00
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7	9.27	0.58	1.16	0.29	0.00
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7	9.25	4.87	2.92	0.49	0.00
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9	9.25	2.78	0.72	0.45	0.99
spinal cord, adult, donor10252.CNhs12227.10159-103A6	9.21	2.08	2.67	0.30	1.78
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6	9.14	2.75	0.50	0.38	0.50
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3	9.08	2.87	0.00	1.43	0.48
vein, adult.CNhs12844.10191-103E2	9.06	2.21	0.20	0.60	0.40
heart, fetal, pool1.CNhs10653.10046-101G1	9.00	3.09	0.40	0.54	0.87
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8	8.98	4.73	0.71	0.71	0.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4	8.95	1.34	0.00	0.45	0.00
thymus, fetal, pool1.CNhs10650.10043-101F7	8.69	1.86	1.92	0.43	0.00
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6	8.52	6.25	1.14	2.27	1.14
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7	8.50	1.06	0.21	0.00	0.00
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7	8.43	1.20	0.00	0.30	0.30
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8	8.39	5.03	2.68	0.34	0.00
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5	8.33	2.86	0.26	0.52	0.78
ductus deferens, adult.CNhs12846.10196-103E7	8.29	0.79	0.39	0.79	0.39
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9	8.27	1.91	0.64	0.64	0.95
rectum, fetal, donor1.CNhs11777.10067-101I4	8.22	2.74	0.00	0.91	0.00
retinoblastoma cell line:Y79.CNhs11267.10475-106I7	8.22	2.05	0.95	0.16	0.16
parietal lobe, fetal, donor1.CNhs11782.10072-101I9	8.20	1.09	0.55	0.00	0.00
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3	8.18	2.44	1.59	0.73	0.73
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9	8.09	1.87	0.62	0.62	0.31
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1	8.04	0.97	0.37	0.12	0.12
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1	8.01	6.40	1.60	0.00	0.00
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5	7.99	3.99	0.00	1.40	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8	7.89	8.72	0.83	2.49	1.25
left atrium, adult, donor1.CNhs11790.10079-102A7	7.86	0.00	2.86	0.71	1.43
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3	7.75	1.41	1.41	0.70	0.00
migratory langerhans cells, donor2.CNhs13536.11902-125F3	7.71	1.33	1.33	0.40	0.27
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9	7.69	5.02	0.31	0.94	0.78
cerebral meninges, adult.CNhs12840.10188-103D8	7.68	1.97	0.00	0.22	1.32
eye, fetal, donor1.CNhs11762.10054-101G9	7.68	1.58	0.90	0.68	0.90
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2	7.65	0.76	3.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6	7.62	1.17	0.00	0.00	0.20
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7	7.55	3.14	0.46	0.35	0.23
tongue, fetal, donor1.CNhs11768.10059-101H5	7.53	1.71	0.00	0.34	0.68
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7	7.44	6.41	1.45	2.07	1.65
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8	7.43	2.56	1.02	1.28	0.77
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6	7.41	6.40	5.39	1.68	0.90
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8	7.40	0.41	1.65	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8	7.39	1.23	1.23	1.23	2.46
hippocampus, adult, donor10252.CNhs12312.10153-102I9	7.35	2.32	1.50	0.41	0.27
occipital pole, adult, pool1.CNhs10643.10036-101E9	7.33	1.52	0.48	0.07	0.07
olfactory region, adult.CNhs12611.10195-103E6	7.27	1.78	1.13	0.00	0.16
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5	7.24	1.32	0.18	0.35	0.18
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5	7.24	2.04	0.72	0.39	0.20
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7	7.18	5.07	2.75	1.27	0.42
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6	7.16	0.98	0.00	0.98	0.33
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4	7.13	7.97	7.34	0.84	1.26
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9	7.13	1.56	0.00	0.52	0.17
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7	7.10	2.45	1.22	0.49	0.49
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9	7.04	0.61	0.31	0.00	0.00
CD8+ T Cells, donor3.CNhs11999.11383-118B6	6.95	4.78	8.11	1.01	0.58
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4	6.90	6.90	7.28	0.38	0.38
thyroid, fetal, donor1.CNhs11769.10060-101H6	6.87	1.21	0.81	0.40	0.40
cerebellum, adult, donor10252.CNhs12323.10166-103B4	6.86	1.44	1.44	0.33	0.00
melanoma cell line:G-361.CNhs11254.10465-106H6	6.85	3.43	0.29	0.29	0.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9	6.78	1.18	5.30	0.00	0.29
seminal vesicle, adult.CNhs12851.10201-103F3	6.77	0.42	1.69	0.85	0.42
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4	6.71	1.68	0.00	0.42	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5	6.69	1.30	0.00	0.56	0.19
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5	6.66	1.01	0.20	0.20	0.00
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6	6.66	1.53	0.87	0.22	0.11
left ventricle, adult, donor1.CNhs11789.10078-102A6	6.62	2.65	0.00	0.66	1.99
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1	6.60	0.00	1.52	0.00	0.00
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2	6.59	6.91	3.21	0.96	1.93
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1	6.58	4.55	6.07	0.76	0.51
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9	6.55	0.87	0.87	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9	6.53	1.04	0.52	0.21	0.10
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3	6.52	2.40	0.86	0.51	0.34
salivary acinar cells, donor2.CNhs12811.11772-123I8	6.49	1.71	0.34	0.68	0.17
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3	6.46	0.50	0.99	0.00	0.00
kidney, adult, pool1.CNhs10622.10017-101C8	6.46	1.18	0.00	0.79	0.32
lymph node, adult, donor1.CNhs11788.10077-102A5	6.45	1.49	2.48	0.50	0.50
substantia nigra, adult, donor10252.CNhs12318.10158-103A5	6.45	1.86	0.86	0.57	0.14
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3	6.42	2.26	0.52	0.35	0.17
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1	6.36	0.88	0.66	0.66	0.00
globus pallidus, adult, donor10252.CNhs12319.10161-103A8	6.30	2.88	0.41	0.27	0.68
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3	6.26	1.35	0.17	0.34	0.17
Mast cell, donor3.CNhs12593.11566-120D9	6.20	9.51	20.03	2.88	2.88
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1	6.10	4.32	0.51	2.03	1.27
pituitary gland - adult, donor10196.CNhs13805.10180-103C9	6.07	1.21	0.61	0.61	0.61
amygdala - adult, donor10196.CNhs13793.10167-103B5	5.96	0.99	0.99	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9	5.96	0.99	0.99	0.00	0.60
frontal lobe, adult, pool1.CNhs10647.10040-101F4	5.89	1.20	0.57	0.06	0.00
insula, adult, pool1.CNhs10646.10039-101F3	5.89	0.43	0.55	0.36	0.06
migratory langerhans cells, donor1.CNhs13535.11901-125F2	5.85	1.17	0.39	0.19	0.58
Neural stem cells, donor1.CNhs11063.11275-116H6	5.84	2.03	0.76	1.27	0.51
testis, adult, pool1.CNhs10632.10026-101D8	5.83	1.21	1.67	0.68	0.45
occipital lobe, fetal, donor1.CNhs11784.10073-102A1	5.80	1.26	0.50	0.00	0.25
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1	5.74	6.17	3.61	1.49	1.28
occipital cortex - adult, donor10196.CNhs13798.10172-103C1	5.67	1.42	0.00	1.42	1.42
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8	5.56	6.31	5.71	1.20	1.50
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6	5.55	0.79	0.79	0.00	0.79
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1	5.52	2.63	1.58	0.26	0.53
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7	5.50	4.47	15.81	0.69	0.00
putamen, adult, donor10196.CNhs12324.10176-103C5	5.50	1.73	0.16	0.31	0.47
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5	5.46	3.82	2.73	0.27	0.55
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9	5.34	1.17	1.33	0.50	0.17
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1	5.33	1.10	0.16	0.00	0.47
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1	5.29	2.65	3.40	0.38	0.76
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2	5.27	2.11	1.32	0.26	0.26
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7	5.23	1.05	5.23	0.00	0.00
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5	5.23	1.00	0.89	0.00	0.00
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4	5.22	1.30	0.52	0.26	0.52
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9	5.15	1.90	6.77	0.00	0.27
pituitary gland, adult, donor10252.CNhs12229.10162-103A9	5.01	0.46	0.23	0.23	0.00
thyroid, adult, pool1.CNhs10634.10028-101E1	4.90	0.95	0.06	0.13	0.51
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6	4.87	2.22	5.10	0.00	0.00
small intestine, fetal, donor1.CNhs11773.10064-101I1	4.81	2.40	0.22	0.87	0.00
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2	4.74	0.26	1.15	0.13	0.00
cerebellum, adult, pool1.CNhs11795.10083-102B2	4.73	0.59	1.18	0.59	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3	4.61	0.92	0.61	0.92	0.00
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4	4.60	0.90	0.64	0.38	0.13
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9	4.57	1.69	0.64	0.40	0.24
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3	4.56	1.71	1.14	0.57	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5	4.54	1.95	0.32	0.32	0.00
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7	4.53	0.95	0.95	0.00	0.00
occipital lobe, adult, donor1.CNhs11787.10076-102A4	4.51	0.82	0.41	0.41	0.21
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2	4.45	2.82	6.08	0.59	0.59
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1	4.40	3.16	0.23	0.56	0.23
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1	4.34	1.81	0.72	0.36	0.00
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8	4.28	2.57	1.71	1.14	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7	4.24	2.93	4.24	0.65	0.65
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4	4.03	0.25	0.76	0.50	0.25
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1	4.01	1.25	0.55	0.00	0.00
skeletal muscle, adult, pool1.CNhs10629.10023-101D5	4.00	2.16	0.10	0.82	0.41
brain, fetal, pool1.CNhs11797.10085-102B4	3.99	2.00	0.00	2.00	2.00
Eosinophils, donor2.CNhs12548.12245-129H4	3.95	5.27	2.64	1.32	2.64
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5	3.93	1.57	0.26	0.00	0.26
dura mater, adult, donor1.CNhs10648.10041-101F5	3.92	2.15	1.71	0.63	0.76
Eosinophils, donor3.CNhs12549.12246-129H5	3.88	0.00	11.63	0.00	3.88
heart, adult, diseased, donor1.CNhs11758.10051-101G6	3.86	2.15	0.43	0.86	0.43
parotid gland, adult.CNhs12849.10199-103F1	3.84	1.10	0.00	0.00	0.55
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8	3.82	1.27	0.96	0.32	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3	3.66	0.70	0.00	0.17	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4	3.59	0.63	1.48	0.21	0.21
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4	3.31	0.66	0.66	0.00	0.00
diencephalon, adult.CNhs12610.10193-103E4	3.28	0.47	0.94	0.00	0.00
cerebellum - adult, donor10196.CNhs13799.10173-103C2	3.05	1.53	0.00	0.00	0.00
CD19+ B Cells, donor2.CNhs12352.11624-122B4	2.94	2.94	3.52	0.59	1.17
Neurons, donor2.CNhs12726.11574-120E8	2.85	1.84	1.68	1.17	0.00
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1	2.84	0.24	0.71	0.00	0.47
thymus, adult, pool1.CNhs10633.10027-101D9	2.65	0.58	0.19	0.00	0.06
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4	2.62	3.10	0.48	0.48	1.67
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3	2.59	1.29	0.00	0.65	0.00
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3	2.56	0.91	2.74	0.18	0.55
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9	2.56	0.85	0.43	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7	2.52	0.47	1.03	0.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5	2.50	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7	2.50	0.83	0.42	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6	2.41	0.75	2.41	0.15	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5	2.37	0.95	8.52	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2	2.32	0.00	0.46	0.00	0.00
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2	2.29	1.69	0.12	0.36	0.12
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1	2.25	0.45	2.56	0.45	0.15
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5	2.16	1.08	2.16	0.00	0.00
pineal gland - adult, donor10196.CNhs13804.10179-103C8	2.14	2.14	0.54	1.61	0.54
throat, fetal, donor1.CNhs11770.10061-101H7	2.14	1.43	0.24	0.00	0.24
amniotic membrane cells, donor2.CNhs12503.12236-129G4	2.08	0.59	0.89	0.59	0.30
Neutrophils, donor3.CNhs11905.11390-118C4	1.66	3.32	3.32	0.83	2.90
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6	1.64	0.00	0.82	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3	1.62	0.97	0.32	0.00	0.32
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9	1.57	1.10	0.94	0.16	0.00
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8	1.49	1.11	0.37	0.00	0.00
migratory langerhans cells, donor3.CNhs13547.11903-125F4	1.47	1.14	0.16	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4	1.34	1.07	5.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4	1.30	0.00	3.26	0.00	0.00
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4	1.30	0.00	1.95	0.00	0.00
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9	1.19	1.59	1.99	0.20	0.40
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4	1.19	0.48	0.00	0.00	0.00
CD19+ B Cells, donor1.CNhs12343.11544-120B5	1.14	0.00	0.00	0.00	0.57
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4	1.14	2.29	1.72	1.14	1.72
pineal gland, adult, donor10252.CNhs12228.10160-103A7	1.01	0.67	0.00	0.00	0.34
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9	0.95	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9	0.95	0.00	0.95	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3	0.89	0.00	0.89	0.00	0.00
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3	0.77	0.29	0.10	0.00	0.00
CD19+ B Cells, donor3.CNhs12354.11705-123B4	0.76	0.76	1.15	0.00	0.00
Neutrophils, donor1.CNhs10862.11233-116C9	0.75	1.50	2.25	0.00	0.00
amniotic membrane cells, donor3.CNhs12379.12237-129G5	0.61	0.00	1.23	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8	0.57	0.57	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5	0.40	0.00	0.00	0.00	0.00
Adipocyte - breast, donor1.CNhs11051.11376-118A8	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7	0.00	1.64	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8	0.00	1.95	11.69	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3	0.00	0.00	0.88	0.00	0.00
Neutrophils, donor2.CNhs11959.11314-117C9	0.00	0.00	0.00	0.00	0.00
blood, adult, pool1.CNhs11761.10053-101G8	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6	0.00	0.00	0.23	0.00	0.00
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9	0.00	0.00	0.67	0.00	0.00

Showing 1 to 889 of 889 entries

0

50

100

150

200

250

300

350

p1@LDLR
p2@LDLR
p3@LDLR
p4@LDLR
p5@LDLR

• Click each plot point to find sample in table

ENCODE TF ChIP-seq peak enrichment analysis Analyst: Erik Arner <br>Summary: For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><br><br>link to source dataset.<br>data

---

No analysis results for this cluster

Details<b>Summary:</b>It includes sequences from the international sequence collaboration, Swiss-Prot, and RefSeq. The RefSeq subset of this file is also available as gene2refseq.<br><br>links to source dataset.<br>human <br>mouse

---

GeneID:	3949
LocusTag:	-
chromosome:	19
map location:	19p13.2
type of gene:	protein-coding
Symbol from nomenclature authority:	LDLR
Full name from nomenclature authority:	low density lipoprotein receptor
Nomenclature status:	O
Other designations:	LDL receptor, low-density lipoprotein receptor, low-density lipoprotein receptor class A domain-containing protein 3, LDL receptor;;low-density lipoprotein receptor;;low-density lipoprotein receptor class A domain-containing protein 3
Modification date:	12.01.2012